{"schema_version":"1","generated_at":"2026-11-03T10:01:21.980Z","data_as_of":null,"url":"https://www.findmykol.com/kol/andrew-sochacki","json_url":"https://www.findmykol.com/kol/andrew-sochacki/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"andrew-sochacki","name":"Andrew Sochacki","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"city":"Grand Rapids","state":"MI","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"}},"identifiers":{"npi":"1003235391","orcid":"0000-0003-1506-7972","openalex":"A5025648824"},"summary":"Andrew Sochacki is an Oncology physician. OpenAlex indexes 24 publications with 763 citations (h-index 10).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":24,"cited_by_count":763,"h_index":10,"latest_activity_year":2025,"source":"works"},"payments":{"company_count":27,"program_years":{"first":2021,"last":null},"rows_total":39,"shown":3,"withheld":36,"rows":[{"payer":"GENZYME CORPORATION","program_year":2025,"amount_usd":78.83,"payment_count":3,"source_url":"https://openpaymentsdata.cms.gov/search?query=1003235391"},{"payer":"Daiichi Sankyo Inc.","program_year":2025,"amount_usd":46.49,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1003235391"},{"payer":"E.R. Squibb & Sons, L.L.C.","program_year":2025,"amount_usd":45.9,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1003235391"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1003235391","source":"payments"},"publications":{"total":26,"shown":5,"withheld":21,"matched_by":"OpenAlex author record","recent":[{"title":"The activin receptor-like kinase-2 inhibitor zilurgisertib (INCB000928) as monotherapy or with ruxolitinib in patients with anemia due to myelofibrosis: Phase 1/2 study final results","year":2025,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2025-3795","status":"verified"},{"title":"A phase 1/2, first-in-human, multicenter, open-label trial evaluating the safety, tolerability, and antileukemic activity of Debio 1562M in patients with recurrent refractory acute myeloid leukemia (AML)","year":2025,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2025-5194","status":"verified"},{"title":"Cost-Effective and Scalable Clonal Hematopoiesis Assay Provides Insight into Clonal Dynamics","year":2024,"journal":"Journal of Molecular Diagnostics","source_url":"https://doi.org/10.1016/j.jmoldx.2024.03.007","status":"verified"},{"title":"Driver mutation zygosity is a critical factor in predicting clonal hematopoiesis transformation risk","year":2024,"journal":"Blood Cancer Journal","source_url":"https://doi.org/10.1038/s41408-023-00974-9","status":"verified"},{"title":"Cost-effective and scalable clonal hematopoiesis assay provides insight into clonal dynamics","year":2023,"journal":"medRxiv","source_url":"https://doi.org/10.1101/2023.11.08.23298270","status":"verified"}],"source":"works"},"contact":{"address_1":"5800 FOREMOST DR SE STE 200","city":"Grand Rapids","state":"MI","zip":"495467062","phone":"616-389-1800","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1003235391","source":"identity"},"similar":[{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":36,"publications":21}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2020-07-01","provider_certified":"2020-07-01","collected_at":"2026-11-03T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}